Company
Blaze Bioscience
Blaze Bioscience develops imaging agents and imaging systems designed to give surgeons real-time, intraoperative visualization of tumor tissue, so more cancer can be removed with greater precision.
Also known as Blaze Bioscience, Inc.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Seattle, WA, United States
- Founded
- 2010
- Customers
- Surgeons, researchers, and healthcare institutions
- Legal name
- Blaze Bioscience, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Blaze Bioscience is a privately held biotechnology company dedicated to improving the lives of cancer patients. Our focus: giving surgeons the real-time visibility they need to remove more cancer with greater precision.
Funding snapshot
- Total raised
- $116MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $8.1M2024-02-15
Funding rounds
- Round, 2024
- $8.1M2024-02-15, SEC form D sold, 2 investors
- Round, 2022
- $25M2022-10-06, SEC form D sold, 3 investors
- Round, 2021
- $15M2021-10-07, SEC form D sold, 6 investors
- Round, 2020
- $10M2020-10-30, SEC form D sold, 1 investor
- Round, 2019
- $20.2M2019-02-01, SEC form D sold, 38 investors
- Round, 2018
- $3M2018-05-10, SEC form D sold, 1 investor
- Round, 2017
- $16.1M2017-10-03, SEC form D sold, 32 investors
- Round, 2017
- $554K2017-06-08, SEC form D sold, 5 investors
- Round, 2015
- $991K2015-12-31, SEC form D sold, 8 investors
- Round, 2013
- $9.7M2013-06-14, SEC form D sold, 27 investors
- Round, 2012
- $6.4M2012-06-06, SEC form D sold, 19 investors
- Round, 2011
- $725K2011-10-03, SEC form D sold, 6 investors
Products
- Hardware
- CANVAS Imaging System
- Other
- Tozuleristide (BLZ-100)
Loading relationship preview